Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
22.4M
-
Shares change
-
+2.69M
-
Total reported value, excl. options
-
$274M
-
Value change
-
+$31.6M
-
Number of buys
-
39
-
Number of sells
-
-32
-
Price
-
$12.24
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q2 2018
82 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2018.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.4M shares
of 106M outstanding shares and own 21.19% of the company stock.
Largest 10 shareholders include Alphabet Inc. (5.05M shares), WELLINGTON MANAGEMENT GROUP LLP (4.4M shares), Foresite Capital Management III, LLC (3.45M shares), EcoR1 Capital, LLC (2.24M shares), BVF INC/IL (960K shares), Partner Fund Management, L.P. (768K shares), Hillhouse Capital Management, Ltd. (767K shares), PRICE T ROWE ASSOCIATES INC /MD/ (644K shares), Board of Trustees of The Leland Stanford Junior University (625K shares), and JANUS HENDERSON GROUP PLC (470K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.